Abbott completed its acquisition of the medical devices company Evalve Inc on November 2 2009. Evalve specialises in the development of devices for minimally invasive repair of mitral valves. Abbott acquired the remaining outstanding equity of Evalve that it did not already own for an upfront payment of US$320 million, plus a US$90 million payment if certain regulatory milestones are met.
November 3, 2009...1:25 pm
Abbott acquires medical devices company Evalve Inc
Jump to Comments
